: 55 (POP) (RA-VD) POP POP 60% 60 [1] 25% ( ) POP POP ; POP-Q POP ; SPSS19.0 t ; Spearman POP P< POP (POP )

Size: px

Start display at page:

Download ": 55 (POP) (RA-VD) POP POP 60% 60 [1] 25% ( ) POP POP ; POP-Q POP ; SPSS19.0 t ; Spearman POP P< POP (POP )"

猛云
5 years ago
Views:

1 54 ( ) JournalofNanchangUniversity(MedicalSciences)2017Vol.57No.5 ( ) : (POP) POP POP 63 (POP ) POP 40 ( ) 2 POP (P<0.05) (P>0.05); (POP-Q) Ⅰ Ⅱ Spearman POP : ; ; : R711.2 ;R445.1 : A : (2017) DOI: /j.cnki.ncdm ApplicationofTransperinealUltrasonographyin DiagnosisofPelvicOrganProlapse ZHANGJieCHENLi (Departmentof Ultrasoundthe FirstAffiliated Hospitalof Nanchang UniversityNanchang330006China) ABSTRACT:Objective Toexplorethevalueoftransperinealultrasonographyindiagnosisofpel- vicorganprolapse(pop)andtoprovideareferenceforultrasonic-assisteddiagnosisandquantita- tiveevaluationofpop.methods Sixty-threepatients with POP(POPgroup)and40patients withoutobviouspop(controlgroup)wereselectedfrom outpatientandinpatientdepartments. Transperinealultrasonographywasperformedtoobservepelvicfloorstructure.Moreoverthepo- sitionandmovementofbladderneckcervixandrectalampulawererecordedduringrestingval- salvaandcontraction.results Therewere10casesofurethraldescending12casesofbladder bulging23casesofuterineprolapse3casesofperinealbodydescending2casesofrectalbulging and13casesofmultipleorganprolapseinpopgroup.thepositionsofbladderneckcervixand rectalampulainpopgroupwerelowerthanthoseincontrolgroup(p<0.05).therewereno significantdiferencesinmovementrangebetweenthetwogroups(p>0.05).thespearmancor- relationcoeficientsbetweenpelvicorganprolapsequantification(pop-q)stageiand Iprolapse andtransperinealultrasonographicevaluationwere0.46and0.83respectively.conclusion The observationofpelvicfloorstructurebytransperinealultrasonographyisofgreatvalueinthediag- nosisandtreatmentofpop. KEY WORDS:transperinealultrasonography;pelvicorganprolapse; pelvicorganprolapsequantification : : (1986 ) : @qq.com

2 : 55 (POP) (RA-VD) POP POP 60% 60 [1] 25% ( ) POP POP ; POP-Q POP ; SPSS19.0 t ; Spearman POP P< POP (POP ) ~77(56.21±8.35) BMI(23.29±1.21)kg m -2 (2.38±1.42); POP ( POP 40 ( ) 39~74(56.53±8.55) BMI (22.94±1.08)kg m -2 (2.40±1.45) 2 (10 12 ); BMI (P>0.05) 23 ; 5 ( ); :13 (2 GE ;2 ;1 VolusonE8 RIC5-9-D ;8 ) 5~9 MHz ) : 22 POP POP BN-VD C-VD RA-VD (P < 0.05) 45 POP (P>0.05) (P<0.05) (Valsalva ) : (P<0.05) (BN-VD) (P<0.05) 1 3 (C-VD)

3 56 ( ) (BN-VD) x±scm n (r) (v) (c) P (r-v) P(r-c) BN-VD r-v BN-VD r-c ± ± ±0.42 <0.05 < ± ±0.40 POP ± ± ±0.83 <0.05 < ± ±0.18 P <0.05 <0.05 <0.05 >0.05 >0.05 r-v: ; r-c: 2 2 (C-VD) x±scm n (r) (v) (c) P (r-v) P(r-c) C-VD r-v C-VD r-c ± ± ±0.46 <0.05 < ± ±0.13 POP ± ± ±1.17 <0.05 < ± ±0.27 P <0.05 <0.05 <0.05 <0.05 < (RA-VD) x±scm n (r) (v) (c) P (r-v) P(r-c) RA-VD r-v RA-VD r-c ± ± ±0.23 <0.05 < ± ±0.13 POP ± ± ±0.64 <0.05 < ± ±0.22 P <0.05 <0.05 <0.05 >0.05 < Ⅰ Ⅱ 1990 Petros IntegralTheory 63 POP : 22 Delancey ( ); POP-Q :33 Ⅰ 36 Ⅱ 9 [2] POP Ⅰ Ⅱ 3.2 POP Spearman Ⅰ (n=33) Ⅱ (n=36) POP-Q 1.42± ± ± ±0.47 : 3 MRI X CT FPFD POP MRI Ⅰ Ⅱ x±scm MRI [3-5] MRI POP 3.1 POP [6] ( ) ( ) ) POP

4 : 57 : % 98% [11] 2 Val- salva ; (ICS)1996 POP-Q POP 3.3 POP 63 POP POP-Q : Valsalva Yalcin [12] : 22 (10 12 ); 23 X 45 ; 5 (3 2 ); :13 (2 ;2 ;1 ;8 ) Dietz POP-Q [7-8] SUI Kluivers [13] POP-Q I 14mm POP 30% 4 : Ⅰ (0.59± [1] 0.30)cm Ⅱ (-1.25±0.47)cm POP-Q Ⅰ (1.42±0.49)cm Ⅱ POP (-0.28±0.53)cm 1cm BN-VD C-VD RA-VD (P< )POP Ⅱ Dietz [714] [15] POP : Ⅰ : ;Ⅱ : 2cm [7-9] SUI POP-Q SUI POP Santoro [10] >1.5cm ( 65 )

5 : 65 Endocrinol (1):1-9. [6] Klein HesselinkE NKlein Hesselink M SdeBockG Hetal. Long-termcardiovascularmortalityinpatientswithdiferentia- tedthyroidcarcinoma:anobservationalstudy[j].jclinoncol (32): [7] RazviSIngoeLKeekaGetal.ThebeneficialefectofL-thy- roxineoncardiovascularriskfactorsendothelialfunctionand qualityoflifeinsubclinicalhypothyroidism:randomizedcross- overtrial[j].jclin Endocrinol Metab200792(5): [8] JabbarAPingitore APearceS Hetal.Thyroidhormones andcardiovasculardisease[j].natrevcardiol201714(1): [9] LevickSFenningABrownL.Increasedcalciuminfluxmedi- atesincreasedcardiacstifnessinhyperthyroidrats[j].cel Biochem Biophys200543(1): [10] KahalyGJDilmann W H.Thyroidhormoneactioninthe heart[j].endocrrev200526(5): phy[j].jclinendocrinolmetab200590(2): [12]. [11] D rrmwolfbrobinsond Metal.Theassociationofthy- roidfunctionwithcardiacmassandleftventricularhypertro- Meta [J]. ( )201252(3): [13] GazdagANagyE VErdeiAetal.Aorticstifnessandleft ventricularfunctionin patients with diferentiatedthyroid cancer[j].jendocrinolinvest201538(2): [14] Klein HesselinkE NLefrandtJDSchuurmansEPetal.In- creasedriskofatrialibrilationaftertreatmentfordiferentia- tedthyroidcarcinoma[j].jclinendocrinolmetab (12): [15] AbdulrahmanR MDelgadoVHoftijzerH Cetal.Bothex- ogenoussubclinicalhyperthyroidismandshort-termoverthy- pothyroidismafectmyocardialstraininpatientswithdifer- entiatedthyroidcarcinoma[j].thyroid201121(5): [16] Tadic MCelicVCuspidiCetal.Howdoessubclinicalhyper- thyroidismafectrightheartfunctionand mechanics [J].J Ultrasound Med201635(2): [17] BiondiBCooperDS.Benefitsofthyrotropinsuppressionversus therisksofadverseefectsindiferentiatedthyroidcancer[j]. Thyroid201020(2): ( : ) 櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐櫐 ( 57 ) : [1]. [M]. : 2008: graphicmeasurementofbladderneck mobilityinthemanage- mentoffemalestressurinaryincontinence[j].gynecolobstet Fertil201139(1): [2] PetrosPE. - [10] SantoroGWieczorekADietzH Petal.Stateoftheart:an [M].. : 2007: [3] integratedapproachtopelvicfloorultrasonography[j].ultra-. MRI soundobstetgynecol201137: [J]. [11] (1): [J]. [4] PizzoferratoA CTimoh K NFritelXetal.Dynamic Magnetic (12): ResonanceImagingandpelvicfloordisorders:howandwhen [J]. [12] Yalcin O THassa HOzalpS.Efectivenessofultrasono- EurJObstetGynecolReprodBiol (181): [5] graphicparametersfordocumentingtheseverityofanatomic Brand o SParente MMascarenhas Tetal.Biomechanical stressincontinence[j].actaobstetgynecolscand studyonthebladderneckandurethralpositions:simulationof (5): impairmentofthepelvicligaments[j].jbiomech201548(2): [13] KluiversKBHendriksJC MShekCetal.Pelvicorganpro [6] lapsesymptomsinrelationtopopqordinalstagesandultra- NotenKJKluiversKBFütererJJetal.Translabialthree- soundprolapseassessment[j].inturogynecolj200819(9): dimensionalultrasonographycomparedwithmagneticresonance imagingindetectinglevatoranidefects[j].obstet Gynecol [14]. [J] (6): (12): [7] DietzH PHaylenBTBroomeJ.Ultrasoundinthequantifica- [15]. POP-Q tionoffemalepelvicorganprolapse[j].ultrasoundobstetgy- [J] (8): necol200118(5): [8] ChantarasornVDietzH P.DiagnosisofCystoceletypebyclin- icalexaminationandpelvicfloorultrasound[j].ultrasoundob- stetgynecol201239(6): [9] Pizzoferrato AFauconnier ABader G.Valueofultrasono- ( : )

冠心病患者ＡｐｏＥ基因多态性及其脂质谱相关性研究正文见第２０页ＡＥ２Ｅ３ＢＥ３Ｅ３ＣＥ４Ｅ４Ｄ

坐标轴为耻骨联合内下缘的水平线与耻骨联合中轴线Ｘ轴夹角４５２静息期张力期缩肛期三种不同状

缩肛期超声声像图表现及ＲＡＶＤＣＶＤＢＮＶＤ的测量完全型ｋａｒｔａｅｎｅｒ综合征１例报告

6 冠心病患者ＡｐｏＥ基因多态性及其脂质谱相关性研究正文见第２０页ＡＥ２Ｅ３ＢＥ３Ｅ３ＣＥ４Ｅ４ＤＥ３Ｅ４图１ＡｐｏＥ基因芯片结果经会阴超声在诊断盆腔脏器脱垂中的应用正文见第５４页１坐标轴为耻骨联合内下缘的水平线与耻骨联合中轴线Ｘ轴夹角４５２静息期张力期缩肛期三种不同状态下ＢＮＶＤ的测值３不同状态下ＣＶＤ的测值４不同状态下ＲＡＶＤ的测值图１静息期张力期缩肛期超声声像图表现及ＲＡＶＤＣＶＤＢＮＶＤ的测量完全型ｋａｒｔａｅｎｅｒ综合征１例报告正文见第９８页ｇＡ示右位心Ｂ脏器反位Ｃ左肺中叶不张及扩张支气管影Ｄ右肺下叶不张及扩张支气管影Ｅ鼻窦炎Ｆ支气管炎图１完全型ＫＳ的影像学表现

: ApoE 21, 1.4 DNA,CHD [1-2] (MRFIT) PCR [3], CHD E(ApoE), (CM) 30s 65 45s (VLDL) β-vldl,apoe, ApoE :50 2min,95 15min;94 45 ; 1.6 DNA ;PCR, : [4

: ApoE 21, 1.4 DNA,CHD [1-2] (MRFIT) PCR [3], CHD E(ApoE), (CM) 30s 65 45s (VLDL) β-vldl,apoe, ApoE :50 2min,95 15min;94 45 ; 1.6 DNA ;PCR, : [4 20 ( )2017 57 5JournalofNanchangUniversity(MedicalSciences)2017,Vol.57No.5 ApoE,, (, 330006) : (,CHD) E(ApoE) 401CHD(CHD ) (TC) (TG) (LDL) (HDL) A1(ApoA1) B(ApoB) a (LPa), CHD (60 )ApoE CHD 6, E2/E2 E3/E3